Stephanie Pei Li Saw

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.

|Aug 11, 2026
Early EGFR inhibition triggers actionable tumour and microenvironmental remodelling in lung cancer.

|Aug 06, 2026
Consensus recommendations for the management of Dato-DXd-associated adverse events in patients with advanced/metastatic NSCLC: insights from a multiregional steering committee.

|Jul 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management.

Maxime Borgeaud, Timothée Olivier, Jair Bar

|Apr 08, 2024
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations.

Chen-Yang Huang, Nanhai Jiang, Meixin Shen

|Oct 14, 2022
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer.

Aaron C Tan, Stephanie P L Saw, Jianbin Chen

Pageof 1

Frequent Collaborators

3 joint publications

Aaron C Tan

3 joint publications

Gillianne G Y Lai

3 joint publications

Anders J Skanderup

3 joint publications

Wan-Teck Lim